NCT03947138View on ClinicalTrials.gov

A Study of GC3107(BCG Vaccine) in Healthy Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

August 6, 2019

Primary Completion Date

June 20, 2022

Study Completion Date

September 6, 2022

Conditions
BCG Vaccination ReactionTuberculosis
Interventions
BIOLOGICAL

GC3107

BCG Vaccine

BIOLOGICAL

Intradermal BCG SSI inj.

BCG Vaccine

Trial Locations (2)

Unknown

The Catholic Universitiy of Korea St. vincent's Hospital, Suwon

Greencross, Yŏngin

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY